Market Dynamics: The fallopian tube cancer market is poised to exhibit a significant revenue compound annual growth rate (CAGR) over the forecast period, driven by the increasing incidence of fallopian tube cancer. Globally, reported cases of fallopian tube cancer range between 1,500 and 2,000. In the United States, ovarian, fallopian tube, and peritoneal cancers collectively represent the top...